| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute cardiac failure after sunitinib
|
Machiels, J.-P.
|
|
|
19 |
3 |
p. 598-599
|
artikel
|
| 2 |
Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2
|
Morel, P.
|
|
|
19 |
3 |
p. 560-565
|
artikel
|
| 3 |
Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome
|
Dietrich, P.-Y.
|
|
|
19 |
3 |
p. 595
|
artikel
|
| 4 |
Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group
|
Bokemeyer, C.
|
|
|
19 |
3 |
p. 448-453
|
artikel
|
| 5 |
Correlation of changes between 2-year disease-free survival and 5-year overall survival in adjuvant breast cancer trials from 1966 to 2006
|
Ng, R.
|
|
|
19 |
3 |
p. 481-486
|
artikel
|
| 6 |
Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancer
|
Lidgren, M.
|
|
|
19 |
3 |
p. 487-495
|
artikel
|
| 7 |
Cost of neutropenic complications of chemotherapy
|
Weycker, D.
|
|
|
19 |
3 |
p. 454-460
|
artikel
|
| 8 |
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens
|
Trümper, L.
|
|
|
19 |
3 |
p. 538-544
|
artikel
|
| 9 |
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin’s lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)
|
Pfreundschuh, M.
|
|
|
19 |
3 |
p. 545-552
|
artikel
|
| 10 |
Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients
|
Muretto, P.
|
|
|
19 |
3 |
p. 516-519
|
artikel
|
| 11 |
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy
|
Colleoni, M.
|
|
|
19 |
3 |
p. 465-472
|
artikel
|
| 12 |
Gastric extranodal marginal zone B-cell lymphomas of MALT type exclusively express toll-like receptor 4 in contrast to other lymphomas infiltrating the stomach
|
Adam, P.
|
|
|
19 |
3 |
p. 566-569
|
artikel
|
| 13 |
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
|
Aapro, M.
|
|
|
19 |
3 |
p. 420-432
|
artikel
|
| 14 |
HSP90 as a marker of progression in melanoma
|
McCarthy, M.M.
|
|
|
19 |
3 |
p. 590-594
|
artikel
|
| 15 |
Inflammatory breast cancer in Tunisia in the era of multimodality therapy
|
Labidi, S.I.
|
|
|
19 |
3 |
p. 473-480
|
artikel
|
| 16 |
in this issue
|
|
|
|
19 |
3 |
p. 405
|
artikel
|
| 17 |
Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer
|
Cottu, P.H.
|
|
|
19 |
3 |
p. 596-597
|
artikel
|
| 18 |
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
|
De Roock, W.
|
|
|
19 |
3 |
p. 508-515
|
artikel
|
| 19 |
Management of bevacizumab-associated bowel perforation: a case series and review of the literature
|
Badgwell, B.D.
|
|
|
19 |
3 |
p. 577-582
|
artikel
|
| 20 |
Measuring the cost of chemotherapy is important, but it is not enough
|
Marino, P.
|
|
|
19 |
3 |
p. 409-410
|
artikel
|
| 21 |
ΔNp63 expression is associated with poor survival in ovarian cancer
|
Marchini, S.
|
|
|
19 |
3 |
p. 501-507
|
artikel
|
| 22 |
Numb chin syndrome as the presenting symptom of carcinomatous meningitis
|
Biasotto, M.
|
|
|
19 |
3 |
p. 599-600
|
artikel
|
| 23 |
Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases
|
|
|
|
19 |
3 |
p. 601
|
artikel
|
| 24 |
Phase III trial of adjuvant 5-fluorouracil and adriamycin versus 5-fluorouracil, adriamycin, and polyadenylic–polyuridylic acid (poly A:U) for locally advanced gastric cancer after curative surgery: final results of 15-year follow-up
|
Jeung, H.-C.
|
|
|
19 |
3 |
p. 520-526
|
artikel
|
| 25 |
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells
|
Bidard, F.-C.
|
|
|
19 |
3 |
p. 496-500
|
artikel
|
| 26 |
Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers
|
Cheng, X.-J.
|
|
|
19 |
3 |
p. 527-532
|
artikel
|
| 27 |
Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience
|
Ku, G.Y.
|
|
|
19 |
3 |
p. 533-537
|
artikel
|
| 28 |
Stage I seminoma and carboplatin risks
|
Horwich, A.
|
|
|
19 |
3 |
p. 407-408
|
artikel
|
| 29 |
Superior survival of females among 10538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site
|
de Vries, E.
|
|
|
19 |
3 |
p. 583-589
|
artikel
|
| 30 |
Survival outcome and cost-effectiveness with docetaxel and paclitaxel in patients with metastatic breast cancer: a population-based evaluation
|
Vu, T.
|
|
|
19 |
3 |
p. 461-464
|
artikel
|
| 31 |
Table of Contents
|
|
|
|
19 |
3 |
p. iv-v
|
artikel
|
| 32 |
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma
|
Overman, M.J.
|
|
|
19 |
3 |
p. 553-559
|
artikel
|
| 33 |
The challenge of biosimilars
|
Mellstedt, H.
|
|
|
19 |
3 |
p. 411-419
|
artikel
|
| 34 |
The impact of follicular lymphoma on health-related quality of life
|
Pettengell, R.
|
|
|
19 |
3 |
p. 570-576
|
artikel
|
| 35 |
The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis
|
Powles, T.
|
|
|
19 |
3 |
p. 443-447
|
artikel
|
| 36 |
Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies
|
Boersma, R.S.
|
|
|
19 |
3 |
p. 433-442
|
artikel
|
Tijdschrift beschrijving